Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
Journal
-
- The Lancet
-
The Lancet 398 (10308), 1344-1357, 2021-10
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1360857595378698368
-
- ISSN
- 01406736
-
- Data Source
-
- Crossref